Insights

Why the Avita Medical (ASX:AVH) share price is slipping lower today

The Avita Medical (ASX: AVH) share price is falling lower today as the company announced its half-year report. We take a closer look.
The post Why the Avita Medical (ASX:AVH) share price is slipping lower today appeared first on The Motley Fool Australia. –

falling healthcare asx share price Mesoblast capital raising

The Avita Medical Inc (ASX: AVH) share price has stayed in the red today since the company announced its half-year results this morning.

At the time of writing, shares in the regenerative medicine company are down 2.66% at a price of $6.23.

A look at the half-year results

For the half-year ending 31 December 2020, Avita Medical reported a substantial revenue increase from the sale of its goods. Revenue rose to $10.16 million up 56% from the previous corresponding period. However, despite the positive returns, net loss also expanded. The company posted a net loss of $15.87 million, which was up 13% from the first half of FY20.

The widening loss may be weighing on investors’ minds this afternoon as the stock is being sold off. But while shareholders will be regretting the fall, shorters of the stock will be pleased as the company continues its troubled run. Avita Medical remains the eighth most shorted stock on the ASX this week.

Moreover, the company reported a disappointing quarterly report last week, which saw its share price slide 11%. In the report, the company announced a strong cash balance of $59.8 million.

Critically it did not provide guidance to the market due to the prevailing uncertainty stemming from the coronavirus pandemic. The small-cap health share advised that its accounts were highly susceptible to the impacts of COVID-19 because its revenue came predominantly from 20 physicians.

About the Avita Medical share price

Avita Medical is a regenerative medicine company based in the United States. The company’s main offering is Recell, a spray-on treatment used for burn victims. Avita currently boasts a market capitalisation of $136 million.

The Avita share price has had a torrid time of late and is down 63% on the same time last year. The share has not fully recovered from the impacts of COVID-19 and remains some way off its 52-week high of $9.11.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Avita Medical Limited. The Motley Fool Australia has recommended Avita Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Avita Medical (ASX:AVH) share price is slipping lower today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!